2022³â ´ëÇѸ鿪ÇÐȸ Ãá°èÇмú´ëȸ(ÇÏÀ̺긮µå)(1ÀÏÂ÷) : 2022-04-14±³À°ÀÏÀÚ : 2022-04-14
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ÄÁº¥¼Ç¼¾ÅÍ ±¤°³Åä°ü
±³À°ÁÖÁ¦ :
2022³â ´ëÇѸ鿪ÇÐȸ Ãá°èÇмú´ëȸ(ÇÏÀ̺긮µå)(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѸ鿪ÇÐȸ
´ã´çÀÚ : ±èÁÖ¿¬
¿¬¶ôó : 02-797-0975
À̸ÞÀÏ :
kai1974info@gmail.com ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, »ê¾÷ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ, ¾à¸®ÇÐ, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 230,000¿ø
ºñ°í [»çÀüµî·Ï ¿ÀÇÁ¶óÀÎ+¿Â¶óÀÎ] Çлýȸ¿ø 8¸¸¿ø ÀϹÝȸ¿ø 12¸¸¿ø ºñȸ¿ø 21¸¸¿ø [ÇöÀåµî·Ï ¿ÀÇÁ¶óÀÎ+¿Â¶óÀÎ] Çлýȸ¿ø 10¸¸¿ø ÀϹÝȸ¿ø 14¸¸¿ø ºñȸ¿ø 23¸¸¿ø [»çÀüµî·Ï ¿Â¶óÀÎ] Çлýȸ¿ø 4¸¸¿ø ÀϹÝȸ¿ø 7¸¸¿ø ºñȸ¿ø 16¸¸¿ø [ÇöÀåµî·Ï ¿Â¶óÀÎ] Çлýȸ¿ø 6¸¸¿ø ÀϹÝȸ¿ø 8¸¸¿ø ºñȸ¿ø 18¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-14 Hall A 12:40~13:10 From Terminology to Insight Shirly Phoon(Beckman Coulter Lifescience)
±³À°½Ã°£ 04-14 Hall A 13:10~13:35 Spatial multi-omics in immunology research ±èÁ¾ÈÆ(¿¬¼¼´ëÇб³)
±³À°½Ã°£ 04-14 Hall A 13:35~13:55 Multimodal and multiscale imaging of CAR T cells in a pancreatic adenocarcinoma xenograft model reveals negative effects of local IL-2 administration Rita Pfeifer(Miltenyi Biotec B.V. & Co. KG)
ÈÞ½Ä 04-14 Hall A 13:55~14:10 ÈÞ½Ä ()
±³À°½Ã°£ 04-14 Hall A 14:10~15:25 Introduction to bulk RNA-seq data analysis ±è±¤¼ö(¼¿ï´ëÇб³)
ÈÞ½Ä 04-14 Hall A 15:25~15:40 ÈÞ½Ä ()
±³À°½Ã°£ 04-14 Hall A 15:40~16:05 Mechanisms of Anticancer Activity of Bacteria in Enhancing Cancer Immunotherapy ¹Úâ¿í(À̹³ë¹ÙÀÌ¿È¢ß)
±³À°½Ã°£ 04-14 Hall A 16:05~16:30 Microbial EV Immunotherapy ±èÀ±±Ù(¢ßMDÇコÄɾî)
±³À°½Ã°£ 04-14 Hall A 16:30~16:55 ABL503, a PD-L1 and 4-1BB Dual-Targeting Bispecific Antibody Á¤ÀçÈ£(¿¡À̺ñ¿¤¹ÙÀÌ¿À¢ß)
ÈÞ½Ä 04-14 Hall A 16:55~17:10 ÈÞ½Ä ()
±³À°½Ã°£ 04-14 Hall A 17:10~17:40 T cell immune responses against SARS-CoV-2 ½ÅÀÇö(IBS)
±³À°½Ã°£ 04-14 Hall A 17:40~18:10 age- and clade-dependent differential parthenogenesis of SARS-CoV-2 in animal models ÃÖ¿µ±â(IBS)